Brookdale Senior Living (BKD) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Adjusted EBITDA grew 20% year-over-year in Q2 2024, with Adjusted Free Cash Flow up 26% and continued operational improvements, including leadership retention and lower associate turnover.
Q2 2024 revenue increased 4.2% year-over-year to $777.5 million, driven by higher resident fees and improved occupancy, but net loss widened to $37.7 million due to the absence of prior year asset sale gains and higher expenses.
Brookdale HealthPlus program expanded, targeting 130 communities by year-end, enhancing resident outcomes and satisfaction.
Brookdale serves approximately 59,000 residents across 649 communities in 41 states, with 94% of resident fees from private pay sources.
Financial highlights
Q2 2024 resident fee revenue increased 4.2% year-over-year to $739.7 million; consolidated RevPAR grew 6.4% and same-community RevPAR rose 5.9%.
Same-community adjusted operating income rose 13%, with margin expanding 160 basis points to 27.4%.
Adjusted EBITDA for Q2 2024 was $97.8 million, up 20% year-over-year; annualized first half Adjusted EBITDA is within 3% of 2019 levels.
Adjusted Free Cash Flow improved 26% to -$6 million; liquidity at $346 million as of June 30, 2024.
Net loss for Q2 2024 was $37.7 million, compared to $4.5 million in Q2 2023, mainly due to the absence of a $36.3 million gain on sale of communities in the prior year.
Outlook and guidance
Q3 2024 guidance: RevPAR growth of 6.25%-6.75% year-over-year; Adjusted EBITDA expected between $90 million and $95 million.
Expects approximately $180 million in net non-development CapEx for 2024, with lower cash usage in the second half.
Guidance reflects favorable occupancy and pricing trends, improved retention, and continued expense management, offset by higher seasonal expenses and incremental marketing spend.
Management expects existing liquidity and cash flows to be sufficient to fund operations and obligations for at least the next 12 months.
Latest events from Brookdale Senior Living
- Operational focus, targeted CapEx, and market-driven M&A support growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Record 2025 EBITDA and occupancy set stage for robust 2026 growth and portfolio streamlining.BKD
Q4 202519 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026 - Strategic acquisitions, strong occupancy, and HealthPlus expansion drive positive 2025 outlook.BKD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Accelerating occupancy, strong cash flow, and innovation position for sustained growth.BKD
Barclays 27th Annual Global Healthcare Conference26 Dec 2025 - 2024 results beat guidance; 2025 targets 11%-15% EBITDA growth and positive cash flow.BKD
Q4 202415 Dec 2025 - Contested director election, performance-based pay, and auditor ratification headline the 2025 proxy.BKD
Proxy Filing1 Dec 2025 - Ortelius seeks to overhaul board leadership to address underperformance and drive value creation.BKD
Proxy Filing1 Dec 2025